SFU health sciences researcher Stefanie Rezansoff has published a new study on the treatment of serious mental illnesses among people who are homeless. This is the first study to investigate adherence to antipsychotic medication ...
Aug 17, 2016
0
17
(HealthDay)—About 25 percent of dementia patients in U.S. nursing homes are still quieted with risky antipsychotic medications. Now, a small study suggests that managing these difficult patients, instead of medicating them, ...
Jul 26, 2016
0
7
Despite minimal evidence supporting their effectiveness to manage symptoms of dementia, the use of antipsychotic drugs in Australian nursing homes is widespread. Studies showing the drugs increase the risk of stroke, cognitive ...
Jul 26, 2016
0
74
Since their development in the 1950s, antipsychotic drugs have been widely used to treat psychoses and neuropsychiatric disorders like schizophrenia. A debilitating side-effect of these drugs called parkinsonism limits their ...
Jul 6, 2016
0
36
More prescriptions for psychotropic drugs in children and adolescents in Germany have been issued than in the past. This is the result of a study reported by Sascha Abbas and colleagues in the current issue of Deutsches Ärzteblatt ...
Jun 21, 2016
0
4
A review of nine observational studies found evidence supporting an increased risk of heart attacks in patients taking antipsychotic drugs. The review expands previous knowledge by demonstrating an increased and more pronounced ...
May 16, 2016
0
2
At least half of Parkinson's disease patients experience psychosis at some point during the course of their illness, and physicians commonly prescribe antipsychotic drugs, such as quetiapine, to treat the condition. However, ...
Mar 21, 2016
0
39
Antipsychotic drugs are initiated in patients with Alzheimer's disease (AD) more frequently than in the general population - already 2-3 years before the Alzheimer's diagnosis, according to a new study from the University ...
Oct 14, 2015
0
19
(HealthDay)—Aristada (aripiprazole lauroxil) extended release injection has been approved by the U.S. Food and Drug Administration to treat the disabling brain disorder schizophrenia, the agency said Tuesday in a news release.
Oct 6, 2015
0
7
Antipsychotic drugs may increase the risk of death in people with Parkinson's disease psychosis (PDP), according to a new study led by researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's ...
Sep 30, 2015
0
16
